The DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
Chemotherapy Side-Effects: Not All DNA Damage Is Equal
Open accessAbstract
Recent advances have increased survival rates of children and adults suffering from cancer thanks to effective anti-cancer therapy, such as chemotherapy. However, during treatment and later in life they are frequently confronted with the severe negative side-effects of their life-saving treatment. The occurrence of numerous features of accelerated aging, seriously affecting quality of life, has now become one of the most pressing problems associated with (pediatric) cancer treatment. Chemotherapies frequently target and damage the DNA, causing mutations or genome instability, a major hallmark of both cancer and aging. However, there are numerous types of chemotherapeutic drugs that are genotoxic and interfere with DNA metabolism in different ways, each with their own biodistribution, kinetics, and biological fate. Depending on the type of DNA lesion produced (e.g., interference with DNA replication or RNA transcription), the organ or cell type inflicted (e.g., cell cycle or differentiation status, metabolic state, activity of clearance and detoxification mechanisms, the cellular condition or micro-environment), and the degree of exposure, outcomes of cancer treatment can largely differ. These considerations provide a conceptual framework in which different classes of chemotherapeutics contribute to the development of toxicities and accelerated aging of different organ systems. Here, we summarize frequently observed side-effects in (pediatric) ex-cancer patients and discuss which types of DNA damage might be responsible.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21590 · Cited by 20,444
Instability and decay of the primary structure of DNA
Lindahl, T. (1993) · Nature · doi:10.1038/362709a0 · Cited by 5,679
Cisplatin in cancer therapy: Molecular mechanisms of action
Dasari, S., & Bernard Tchounwou, P. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.025 · Cited by 5,537
5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332
The resurgence of platinum-based cancer chemotherapy
Kelland, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2167 · Cited by 4,717
Yang, W., Soares, J., Greninger, P., Edelman, E. J., Lightfoot, H., Forbes, S., Bindal, N., Beare, D., Smith, J. A., Thompson, I. R., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1111 · Cited by 4,051
Genome maintenance mechanisms for preventing cancer
Hoeijmakers, J. H. J. (2001) · Nature · doi:10.1038/35077232 · Cited by 3,939
Childhood and adolescent cancer statistics, 2014
Ward, E., DeSantis, C., Robbins, A., Kohler, B., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21219 · Cited by 2,412
Topoisomerase I inhibitors: camptothecins and beyond
Pommier, Y. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1977 · Cited by 2,277
Hoeijmakers, J. H. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804615 · Cited by 2,239
Understanding the odd science of aging
Kirkwood, T. B. L. (2005) · Cell · doi:10.1016/j.cell.2005.01.027 · Cited by 1,984
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Zhang, S., Liu, X., Bawa-Khalfe, T., Lu, L.-S., Lyu, Y. L., Liu, L. F., & Yeh, E. T. H. (2012) · Nature Medicine · doi:10.1038/nm.2919 · Cited by 1,948
Farber, S., Diamond, L. K., Mercer, R. D., Sylvester, R. F., & Wolff, J. A. (1948) · New England Journal of Medicine · doi:10.1056/nejm194806032382301 · Cited by 1,806
Targeting DNA topoisomerase II in cancer chemotherapy
Nitiss, J. L. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2607 · Cited by 1,791
The side effects of platinum-based chemotherapy drugs: a review for chemists
Oun, R., Moussa, Y. E., & Wheate, N. J. (2018) · Dalton Transactions · doi:10.1039/c8dt00838h · Cited by 1,737
Smith, T. J., Khatcheressian, J., Lyman, G. H., Ozer, H., Armitage, J. O., Balducci, L., Bennett, C. L., Cantor, S. B., Crawford, J., Cross, S. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.4451 · Cited by 1,636
Mechanisms of Cisplatin Nephrotoxicity
Miller, R. P., Tadagavadi, R. K., Ramesh, G., & Reeves, W. B. (2010) · Toxins · doi:10.3390/toxins2112490 · Cited by 1,622
Effects of intermittent fasting on health, aging, and disease
de Cabo, R., & Mattson, M. P. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1905136 · Cited by 1,605
Molecular mechanisms of resistance and toxicity associated with platinating agents
Rabik, C. A., & Dolan, M. E. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.09.006 · Cited by 1,564
Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase II
Tewey, K. M., Rowe, T. C., Yang, L., Halligan, B. D., & Liu, L. F. (1984) · Science · doi:10.1126/science.6093249 · Cited by 1,538
Schirrmacher, V. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4661 · Cited by 1,296
Cardiovascular Complications of Cancer Therapy
Yeh, E. T. H., & Bickford, C. L. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.050 · Cited by 1,275
Clinical Ascertainment of Health Outcomes Among Adults Treated for Childhood Cancer
Hudson, M. M., Ness, K. K., Gurney, J. G., Mulrooney, D. A., Chemaitilly, W., Krull, K. R., Green, D. M., Armstrong, G. T., Nottage, K. A., Jones, K. E., et al. (2013) · JAMA · doi:10.1001/jama.2013.6296 · Cited by 1,248
Understanding nucleotide excision repair and its roles in cancer and ageing
Marteijn, J. A., Lans, H., Vermeulen, W., & Hoeijmakers, J. H. J. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3822 · Cited by 1,192
Cyclophosphamide and cancer: golden anniversary
Emadi, A., Jones, R. J., & Brodsky, R. A. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.146 · Cited by 1,050
Cellular senescence drives age-dependent hepatic steatosis
Ogrodnik, M., Miwa, S., Tchkonia, T., Tiniakos, D., Wilson, C. L., Lahat, A., Day, C. P., Burt, A., Palmer, A., Anstee, Q. M., et al. (2017) · Nature Communications · doi:10.1038/ncomms15691 · Cited by 1,044
Self-citationDNA interstrand crosslink repair and cancer
Deans, A. J., & West, S. C. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3088 · Cited by 1,023
Epidemiology of childhood cancer
Kaatsch, P. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.02.003 · Cited by 978
The central role of DNA damage in the ageing process
Schumacher, B., Pothof, J., Vijg, J., & Hoeijmakers, J. H. J. (2021) · Nature · doi:10.1038/s41586-021-03307-7 · Cited by 907
De Ruysscher, D., Niedermann, G., Burnet, N. G., Siva, S., Lee, A. W. M., & Hegi-Johnson, F. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0064-5 · Cited by 868
Medical Assessment of Adverse Health Outcomes in Long-term Survivors of Childhood Cancer
Geenen, M. M., Cardous-Ubbink, M. C., Kremer, L. C. M., van den Bos, C., van der Pal, H. J. H., Heinen, R. C., Jaspers, M. W. M., Koning, C. C. E., Oldenburger, F., Langeveld, N. E., et al. (2007) · JAMA · doi:10.1001/jama.297.24.2705 · Cited by 860
Cellular pharmacology of gemcitabine
Mini, E., Nobili, S., Caciagli, B., Landini, I., & Mazzei, T. (2006) · Annals of Oncology · doi:10.1093/annonc/mdj941 · Cited by 842
Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
Albini, A., Pennesi, G., Donatelli, F., Cammarota, R., De Flora, S., & Noonan, D. M. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp440 · Cited by 839
Armstrong, G. T., Liu, Q., Yasui, Y., Neglia, J. P., Leisenring, W., Robison, L. L., & Mertens, A. C. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.1425 · Cited by 776
Chemotherapy‐induced peripheral neurotoxicity: A critical analysis
Park, S. B., Goldstein, D., Krishnan, A. V., Lin, C. S., Friedlander, M. L., Cassidy, J., Koltzenburg, M., & Kiernan, M. C. (2013) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21204 · Cited by 741
Cardiotoxicity of Chemotherapeutic Agents: Incidence, Treatment and Prevention
Pai, V. B., & Nahata, M. C. (2000) · Drug Safety · doi:10.2165/00002018-200022040-00002 · Cited by 729
Repair of Endogenous DNA Damage
LINDAHL, T., & BARNES, D. E. (2000) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2000.65.127 · Cited by 714
GOODMAN, L. S. (1946) · Journal of the American Medical Association · doi:10.1001/jama.1946.02870380008004 · Cited by 700
Cisplatin nephrotoxicity: a review of the literature
Manohar, S., & Leung, N. (2018) · Journal of Nephrology · doi:10.1007/s40620-017-0392-z · Cited by 636
Effect of anthracycline antibiotics on oxygen radical formation in rat heart.
Doroshow, J. H. (1983) · PubMed · Cited by 629
Toxicity of platinum compounds
Hartmann, J. T., & Lipp, H.-P. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.6.889 · Cited by 604
Eukaryotic Translesion Polymerases and Their Roles and Regulation in DNA Damage Tolerance
Waters, L. S., Minesinger, B. K., Wiltrout, M. E., D'Souza, S., Woodruff, R. V., & Walker, G. C. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00034-08 · Cited by 591
Chemotherapy-induced peripheral neurotoxicity (CIPN): An update
Argyriou, A. A., Bruna, J., Marmiroli, P., & Cavaletti, G. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.04.012 · Cited by 568
Merritt, A. J., Potten, C. S., Kemp, C. J., Hickman, J. A., Balmain, A., Lane, D. P., & Hall, P. A. (1994) · PubMed · Cited by 560
Knight, K. R. G., Kraemer, D. F., & Neuwelt, E. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.5355 · Cited by 542
Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases
Zorzi, D., Laurent, A., Pawlik, T. M., Lauwers, G. Y., Vauthey, J.-N., & Abdalla, E. K. (2007) · British Journal of Surgery · doi:10.1002/bjs.5719 · Cited by 532
Formation and Repair of Interstrand Cross-Links in DNA
Noll, D. M., Mason, T. M., & Miller, P. S. (2006) · Chemical Reviews · doi:10.1021/cr040478b · Cited by 484
Gates, K. S. (2009) · Chemical Research in Toxicology · doi:10.1021/tx900242k · Cited by 484
Hepatotoxicity of Chemotherapy
King, P. D., & Perry, M. C. (2001) · The Oncologist · doi:10.1634/theoncologist.6-2-162 · Cited by 454
Pang, B., Qiao, X., Janssen, L., Velds, A., Groothuis, T., Kerkhoven, R., Nieuwland, M., Ovaa, H., Rottenberg, S., van Tellingen, O., et al. (2013) · Nature Communications · doi:10.1038/ncomms2921 · Cited by 420
Martins, I., Kepp, O., Schlemmer, F., Adjemian, S., Tailler, M., Shen, S., Michaud, M., Menger, L., Gdoura, A., Tajeddine, N., et al. (2011) · Oncogene · doi:10.1038/onc.2010.500 · Cited by 414
New insights into the activities and toxicities of the old anticancer drug doxorubicin
van der Zanden, S. Y., Qiao, X., & Neefjes, J. (2021) · The FEBS Journal · doi:10.1111/febs.15583 · Cited by 410
Collateral Damage in Cancer Chemotherapy: Oxidative Stress in Nontargeted Tissues
Chen, Y., Jungsuwadee, P., Vore, M., Butterfield, D. A., & St. Clair, D. K. (2007) · Molecular Interventions · doi:10.1124/mi.7.3.6 · Cited by 387
Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update
dos Santos, N. A. G., Carvalho Rodrigues, M. A., Martins, N. M., & dos Santos, A. C. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0821-7 · Cited by 378
Swenberg, J. A., Lu, K., Moeller, B. C., Gao, L., Upton, P. B., Nakamura, J., & Starr, T. B. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfq371 · Cited by 377
Talcott, J. A. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.12.2561 · Cited by 363
Total body irradiation selectively induces murine hematopoietic stem cell senescence.
Wang, Y., Schulte, B. A., LaRue, A. C., Ogawa, M., & Zhou, D. (2006) · Blood · doi:10.1182/blood-2005-04-1418 · Cited by 351
Lyman, G. H., Abella, E., & Pettengell, R. (2014) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.12.006 · Cited by 348
Szebeni, J., Alving, C. R., & Muggia, F. M. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.4.300 · Cited by 341
Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer
Bokemeyer, C., Berger, C., Hartmann, J., Kollmannsberger, C., Schmoll, H., Kuczyk, M., & Kanz, L. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.226 · Cited by 339
Sparreboom, A., van Tellingen, O., Nooijen, W. J., & Beijnen, J. H. (1996) · PubMed · Cited by 313
Fricker, L. D. (2020) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023603 · Cited by 309
Crivellari, D., Bonetti, M., Castiglione-Gertsch, M., Gelber, R. D., Rudenstam, C.-M., Thürlimann, B., Price, K. N., Coates, A. S., Hürny, C., Bernhard, J., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.7.1412 · Cited by 291
Perazella, M. A., & Moeckel, G. W. (2010) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2010.09.005 · Cited by 287
Hepatotoxicity of Chemotherapy
Floyd, J., Mirza, I., Sachs, B., & Perry, M. C. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.11.002 · Cited by 279
Lessons from human progeroid syndromes
Martin, G. M., & Oshima, J. (2000) · Nature · doi:10.1038/35041705 · Cited by 261
Capranico, G., Tinelli, S., Austin, C. A., Fisher, M. L., & Zunino, F. (1992) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(92)90050-a · Cited by 258
Yoshioka, A., Tanaka, S., Hiraoka, O., Koyama, Y., Hirota, Y., Ayusawa, D., Seno, T., Garrett, C., & Wataya, Y. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47554-0 · Cited by 252
Gastrointestinal Toxicity of Chemotherapeutic Agents
Mitchell, E. P. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.12.001 · Cited by 242
Oxidative destruction of erythrocyte ghost membranes catalyzed by the doxorubicin-iron complex
Myers, C. E., Gianni, L., Simone, C. B., Klecker, R., & Greene, R. (1982) · Biochemistry · doi:10.1021/bi00537a001 · Cited by 239
Chemotherapy-induced peripheral neurotoxicity
Cavaletti, G., & Marmiroli, P. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000234 · Cited by 239
Molecular Basis of Anthracycline-Induced Cardiotoxicity and Its Prevention
Horenstein, M. S., Vander Heide, R. S., & L'Ecuyer, T. J. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3043 · Cited by 228
Hematologic complications of cancer chemotherapy.
Hoagland, H. C. (1982) · PubMed · Cited by 226
Gastro-intestinal toxicity of chemotherapeutics in colorectal cancer: The role of inflammation
Lee, C. S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i14.3751 · Cited by 224
Hepatic Radiation Toxicity: Avoidance and Amelioration
Guha, C., & Kavanagh, B. D. (2011) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2011.05.003 · Cited by 222
Gastrointestinal complications of pelvic radiotherapy: are they of any importance?
Andreyev, J. (2005) · Gut · doi:10.1136/gut.2004.062596 · Cited by 221
Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721
Mollman, J. E., Glover, D. J., Hogan, W. M., & FURMAN, R. E. (1988) · Cancer · doi:10.1002/1097-0142(19880601)61:11<2192::aid-cncr2820611110>3.0.co;2-a · Cited by 219
Measuring Aging and Identifying Aging Phenotypes in Cancer Survivors
Guida, J. L., Ahles, T. A., Belsky, D., Campisi, J., Cohen, H. J., DeGregori, J., Fuldner, R., Ferrucci, L., Gallicchio, L., Gavrilov, L., et al. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djz136 · Cited by 216
Torrisi, J. M., Schwartz, L. H., Gollub, M. J., Ginsberg, M. S., Bosl, G. J., & Hricak, H. (2011) · Radiology · doi:10.1148/radiol.10092129 · Cited by 215
Biology of premature ageing in survivors of cancer
Cupit-Link, M. C., Kirkland, J. L., Ness, K. K., Armstrong, G. T., Tchkonia, T., LeBrasseur, N. K., Armenian, S. H., Ruddy, K. J., & Hashmi, S. K. (2017) · ESMO Open · doi:10.1136/esmoopen-2017-000250 · Cited by 214
DNA damage is an early event in doxorubicin-induced cardiac myocyte death
L'Ecuyer, T., Sanjeev, S., Thomas, R., Novak, R., Das, L., Campbell, W., & Heide, R. V. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00738.2005 · Cited by 212
Mechanisms of Toxic Damage to Spermatogenesis
Boekelheide, K. (2005) · Journal of the National Cancer Institute Monographs · doi:10.1093/jncimonographs/lgi006 · Cited by 212
A Comparative Study of Two Regimens of Combination Chemotherapy in Acute Leukemia
FREI, E., HOLLAND, J. F., SCHNEIDERMAN, M. A., PINKEL, D., SELKIRK, G., FREIREICH, E. J., SILVER, R. T., GOLD, G. L., & REGELSON, W. (1958) · Blood · doi:10.1182/blood.v13.12.1126.1126 · Cited by 179
Ototoxicity From Cisplatin Therapy in Childhood Cancer
Coradini, P. P., Cigana, L., Selistre, S. G. A., Rosito, L. S., & Brunetto, A. L. (2007) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e318059c220 · Cited by 175
Chemotherapy-Induced Cardiotoxicity
Shaikh, A. Y., & Shih, J. A. (2012) · Current Heart Failure Reports · doi:10.1007/s11897-012-0083-y · Cited by 174
Nephrotoxicity in cancer treatment: An overview
Santos, M. L. C., de Brito, B. B., da Silva, F. A. F., Botelho, A. C. D. S., & de Melo, F. F. (2020) · World Journal of Clinical Oncology · doi:10.5306/wjco.v11.i4.190 · Cited by 167
Cardiotoxicity of Cancer Chemotherapy: Implications for Children
Simbre, V. C., Duffy, S. A., Dadlani, G. H., Miller, T. L., & Lipshultz, S. E. (2005) · Pediatric Drugs · doi:10.2165/00148581-200507030-00005 · Cited by 166
Shahid, F., Farooqui, Z., & Khan, F. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.03.009 · Cited by 166
Possible acceleration of aging by adjuvant chemotherapy: A cause of early onset frailty?
MacCormick, R. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.01.045 · Cited by 164
Inhibition of Topoisomerase (DNA) I (TOP1): DNA Damage Repair and Anticancer Therapy
Xu, Y., & Her, C. (2015) · Biomolecules · doi:10.3390/biom5031652 · Cited by 164
Improving the outcome for children with cancer: Development of targeted new agents
Adamson, P. C. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21273 · Cited by 162
Florescu, M., Cintezǎ, M., & Vinereanu, D. (2011) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328349761c · Cited by 162
Uncoupling DNA damage from chromatin damage to detoxify doxorubicin
Qiao, X., van der Zanden, S. Y., Wander, D. P. A., Borràs, D. M., Song, J.-Y., Li, X., van Duikeren, S., van Gils, N., Rutten, A., van Herwaarden, T., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1922072117 · Cited by 161
Nephrotoxicity of anticancer treatment
Małyszko, J., Kozłowska, K., Kozłowski, L., & Małyszko, J. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw338 · Cited by 159
Moudi, M., Go, R., Yien, C. Y. S., et al. (2013) · PubMed · Cited by 159
Blockade of TLR3 protects mice from lethal radiation-induced gastrointestinal syndrome
Takemura, N., Kawasaki, T., Kunisawa, J., Sato, S., Lamichhane, A., Kobiyama, K., Aoshi, T., Ito, J., Mizuguchi, K., Karuppuchamy, T., et al. (2014) · Nature Communications · doi:10.1038/ncomms4492 · Cited by 158
Cancer Treatment as an Accelerated Aging Process: Assessment, Biomarkers, and Interventions
Hurria, A., Jones, L. W., & Muss, H. B. (2016) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_156160 · Cited by 158
The double-edged sword: Neurotoxicity of chemotherapy
Magge, R., & DeAngelis, L. M. (2014) · Blood Reviews · doi:10.1016/j.blre.2014.09.012 · Cited by 154
Drug-induced crystal nephropathy: an update
Yarlagadda, S. G., & Perazella, M. A. (2008) · Expert Opinion on Drug Safety · doi:10.1517/14740338.7.2.147 · Cited by 154
Prevention of chemotherapy-induced ovarian damage
Roness, H., Kashi, O., & Meirow, D. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.11.043 · Cited by 151
Hydroxyl radical production and DNA damage induced by anthracycline‐iron complex
Muindi, J. R., Sinha, B. K., Gianni, L., & Myers, C. E. (1984) · FEBS Letters · doi:10.1016/0014-5793(84)81130-8 · Cited by 150
Cisplatin Ototoxicity: Involvement of Iron and Enhanced Formation of Superoxide Anion Radicals
Dehne, N., Lautermann, J., Petrat, F. M., Rauen, U., & de GROOT, H. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9171 · Cited by 148
Cardiotoxicity Induced by Chemotherapy and Antibody Therapy
Yeh, E. T. H. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.57.121304.131240 · Cited by 146
DNA replication stress and cancer chemotherapy
Kitao, H., Iimori, M., Kataoka, Y., Wakasa, T., Tokunaga, E., Saeki, H., Oki, E., & Maehara, Y. (2017) · Cancer Science · doi:10.1111/cas.13455 · Cited by 146
Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy
Shayne, M., Culakova, E., Poniewierski, M. S., Wolff, D. A., Dale, D. C., Crawford, J., & Lyman, G. H. (2007) · Cancer · doi:10.1002/cncr.22939 · Cited by 145
From DNA damage to mutations: All roads lead to aging
Vijg, J. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101316 · Cited by 142
Membrane transporters as mediators of cisplatin side-effects.
Ciarimboli, G. (2014) · PubMed · Cited by 141
Genome Integrity in Aging: Human Syndromes, Mouse Models, and Therapeutic Options
Vermeij, W. P., Hoeijmakers, J. H. J., & Pothof, J. (2015) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124316 · Cited by 136
Self-citationBowel injury: current and evolving management strategies
Hauer‐Jensen, M., Wang, J., & Denham, J. W. (2003) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(03)00032-8 · Cited by 136
Chemotherapy-Related Neurotoxicity
Taillibert, S., Rhun, É. L., & Chamberlain, M. C. (2016) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-016-0686-x · Cited by 133
Petr, M. A., Tulika, T., Carmona-Marin, L. M., & Scheibye‐Knudsen, M. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.12.001 · Cited by 133
Kidera, Y., Kawakami, H., Sakiyama, T., Okamoto, K., Tanaka, K., Takeda, M., Kaneda, H., Nishina, S., Tsurutani, J., Fujiwara, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101902 · Cited by 131
Cancer Treatment-Induced Accelerated Aging in Cancer Survivors: Biology and Assessment
Wang, S., Prizment, A. E., Thyagarajan, B., & Blaes, A. H. (2021) · Cancers · doi:10.3390/cancers13030427 · Cited by 130
Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer
Kooijmans, E. C. M., Bökenkamp, A., Tjahjadi, N. S., Tettero, J. M., Broeder, E. V. D., van der Pal, H. J. H., & Veening, M. A. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008944.pub3 · Cited by 129
Causes of reversible nephrogenic diabetes insipidus: a systematic review
Garofeanu, C. G., Weir, M., Rosas-Arellano, M. P., Henson, G., Garg, A. X., & Clark, W. F. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.01.008 · Cited by 128 · cited 1×
“This so-called nephrogenic diabetes insipidus (NDI) will result in polyuria causing severe dehydration and electrolyte imbalances [29,79].”
BackgroundNephrotoxicity of recent anti-cancer agents
Lameire, N. H. (2013) · Clinical Kidney Journal · doi:10.1093/ckj/sft135 · Cited by 121
Mammalian DNA base excision repair: Dancing in the moonlight
Caldecott, K. W. (2020) · DNA repair · doi:10.1016/j.dnarep.2020.102921 · Cited by 121
Role of transporters in the distribution of platinum-based drugs
Harrach, S., & Ciarimboli, G. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00085 · Cited by 114
High Uric Acid Induces Insulin Resistance in Cardiomyocytes In Vitro and In Vivo
Li, Z., Zhu, Y., Huang, T., Hisatome, I., Yamamoto, T., & Jidong, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147737 · Cited by 112
What lies behind chemotherapy-induced ovarian toxicity?
Ben‐Aharon, I., & Shalgi, R. (2012) · Reproduction · doi:10.1530/rep-12-0121 · Cited by 109
Membrane Transporters as Mediators of Cisplatin Effects and Side Effects
Ciarimboli, G. (2012) · Scientifica · doi:10.6064/2012/473829 · Cited by 105
Clemens, E., de Vries, A., Pluijm, S. F. M., Zehnhoff‐Dinnesen, A. A., Tissing, W. J. E., Loonen, J. J., Broeder, E. V. D., Bresters, D., Versluys, B. A. B., Kremer, L. C. M., et al. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.09.023 · Cited by 100
Premature Aging in Young Cancer Survivors
Armenian, S. H., Gibson, C. J., Rockne, R. C., & Ness, K. K. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy229 · Cited by 100
Cardiovascular disease in cancer survivors
Okwuosa, T. M., Anzevino, S., & Rao, R. (2017) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2016-134417 · Cited by 97
Secombe, K. R., Coller, J. K., Gibson, R. J., Wardill, H. R., & Bowen, J. M. (2018) · International Journal of Cancer · doi:10.1002/ijc.31836 · Cited by 94
Thrombocytopenia in Adult Cancer Patients Receiving Cytotoxic Chemotherapy
ten Berg, M. J., van den Bemt, P. M. L. A., Shantakumar, S., Bennett, D., Voest, E. E., Huisman, A., van Solinge, W. W., & Egberts, T. C. G. (2011) · Drug Safety · doi:10.2165/11594310-000000000-00000 · Cited by 84
Aging: not all DNA damage is equal
Vermeij, W. P., Hoeijmakers, J. H. J., & Pothof, J. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2014.06.006 · Cited by 72
Self-citationChemotherapy-Induced Hepatotoxicity
Thatishetty, A. V., Agresti, N., & O’Brien, C. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.07.010 · Cited by 65
Prevention of cisplatin nephrotoxicity
Broe, M. E. D., & Wedeen, R. P. (1986) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(86)90001-5 · Cited by 64
Pharmacokinetics in the child.
Crom, W. R. (1994) · Environmental Health Perspectives · doi:10.1289/ehp.94102s11111 · Cited by 64
DNA Double Strand Break Repair Pathways in Response to Different Types of Ionizing Radiation
van de Kamp, G., Heemskerk, T., Kanaar, R., & Essers, J. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.738230 · Cited by 64
Prevention of cisplatin nephrotoxicity.
Hayati, F., Hossainzadeh, M., Shayanpour, S., Abedi-Gheshlaghi, Z., & Mousavi, S. S. B. (2016) · PubMed Central · Cited by 62
Clinical and Preclinical Modulation of Chemotherapy-Induced Toxicity in Patients with Cancer
Hoekman, K., van der Vijgh, W. J. F., & Vermorken, J. B. (1999) · Drugs · doi:10.2165/00003495-199957020-00002 · Cited by 57
Mitomycin C-enhanced superoxide and hydrogen peroxide formation in rat heart.
Doroshow, J. H. (1981) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32653-4 · Cited by 56
Chrischilles, E. A., Link, B. K., Scott, S. D., Delgado, D. J., & Fridman, M. (2003) · Cancer Control · doi:10.1177/107327480301000507 · Cited by 53
Analysis of genetic and non genetic risk factors for cisplatin ototoxicity in pediatric patients
Olgun, Y., Aktaş, S., Altun, Z. S., et al. (2016) · International Journal of Pediatric Otorhinolaryngology · doi:10.1016/j.ijporl.2016.09.001 · Cited by 46
After surviving cancer, what about late life effects of the cure?
Nonnekens, J., & Hoeijmakers, J. H. J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201607062 · Cited by 42
Prevention of Chemotherapy-Induced Nephrotoxicity in Children with Cancer
Sharbaf, F. G., Farhangi, H., & Assadi, F. K. (2017) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_40_17 · Cited by 40
Ilinskaya, A. N., Clogston, J. D., McNeil, S. E., & Dobrovolskaia, M. A. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.07.012 · Cited by 33
Nutritional Preconditioning in Cancer Treatment in Relation to DNA Damage and Aging
van den Boogaard, W. M. C., van den Heuvel‐Eibrink, M. M., Hoeijmakers, J. H. J., & Vermeij, W. P. (2020) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-060820-090737 · Cited by 33
Self-citationComprehensive Analysis of Chemotherapeutic Agents That Induce Infectious Neutropenia
Okunaka, M., Kano, D., Matsui, R., Kawasaki, T., & Uesawa, Y. (2021) · Pharmaceuticals · doi:10.3390/ph14070681 · Cited by 31
Aspects on Reducing Gastrointestinal Adverse Effects Associated with Radiotherapy
Roger Henriksson, P. B. (1999) · Acta Oncologica · doi:10.1080/028418699431564 · Cited by 30
Fernandes, R., Mazzarello, S., Stober, C., Vandermeer, L., Dudani, S., Ibrahim, M. F. K., Majeed, H., Perdrizet, K., Shorr, R., Hutton, B., et al. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-4028-0 · Cited by 27
Oosterom, N., Griffioen, P. H., den Hoed, M. A. H., Pieters, R., de Jonge, R., Tissing, W. J. E., van den Heuvel‐Eibrink, M. M., & Heil, S. G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199574 · Cited by 26
Meijer, A. J. M., Diepstraten, F. A., Langer, T., Broer, L., Domingo, I. K., Clemens, E., Uitterlinden, A. G., de Vries, A. C. H., van Grotel, M., Vermeij, W. P., et al. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00178-z · Cited by 25
Self-citationNephrotoxic Chemotherapy Agents: Old and New
Nicolaysen, A. (2020) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2019.08.005 · Cited by 23
Chemotherapy-associated hepatotoxicity in colorectal cancer.
Cai, Z., Yang, J., Shu, X., & Xiong, X. (2014) · PubMed · Cited by 19
Wardill, H. R., Ferreira, A. R. D. S., Cloo, S. L., Havinga, R., Harmsen, H. J. M., Vermeij, W. P., & Tissing, W. J. E. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1809332 · Cited by 16
Self-citationBraña, I., Zamora, E., Oristrell, G., & Tabernero, J. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-70253-7_14 · Cited by 10
Research works printed but not linked: 22
- Schulpen, 2021, Significant improvement in survival of advanced stage childhood and young adolescent cancer in the Netherlands since the 1990s, Eur. J. Cancer, 157, 81, 10.1016/j.ejca.2021.08.001 · DOI
- Caglar, 2002, Cumulative prior dose of cisplatin as a cause of the nephrotoxicity of high-dose chemotherapy followed by autologous stem-cell transplantation, Nephrol. Dial. Transplant., 17, 1931, 10.1093/ndt/17.11.1931 · doi:10.1093/ndt/17.11.1931
- Fukasawa, 2014, Anti-cancer agent-induced nephrotoxicity, Anticancer Agents Med. Chem., 14, 921, 10.2174/1871520614666140127105809 · doi:10.2174/1871520614666140127105809
- Grigorian, 2014, Hepatotoxicity secondary to chemotherapy, J. Clin. Transl. Hepatol., 2, 95
- Madeddu, 2016, Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy, J. Cardiovasc. Med., 17, S12, 10.2459/JCM.0000000000000376 · doi:10.2459/jcm.0000000000000376
- Elliott, 2006, Pathogenesis of cardiotoxicity induced by anthracyclines, Semin. Oncol., 33, 2, 10.1053/j.seminoncol.2006.04.020 · doi:10.1053/j.seminoncol.2006.04.020
- Tamamyan, 2016, Chemotherapy induced thrombocytopenia in pediatric oncology, Crit. Rev. Oncol. Hematol., 99, 299, 10.1016/j.critrevonc.2016.01.005 · doi:10.1016/j.critrevonc.2016.01.005
- Lokich, 1976, Managing chemotherapy-induced bone marrow suppression in cancer, Hosp. Pract., 11, 61, 10.1080/21548331.1976.11706980 · doi:10.1080/21548331.1976.11706980
- Germanas, 2002, Alkylating agents, Dermatol. Ther., 15, 317, 10.1046/j.1529-8019.2002.01540.x · doi:10.1046/j.1529-8019.2002.01540.x
- Waweru, 2007, Chemotherapy induced myelosuppression, East Afr. Med. J., 84, 8
- Corral, 2016, Cerebellar toxicity due to cytarabine: A series of 4 cases, Neurol. A, 7, 491
- Ferrazzi, 1991, DNA damage and cytotoxicity induced by metabolites of anthracycline antibiotics, doxorubicin and idarubicin, Cancer Commun., 3, 173, 10.3727/095535491820873308 · doi:10.3727/095535491820873308
- Sawyer, 2013, Anthracyclines and Heart Failure, N. Engl. J. Med., 368, 1154, 10.1056/NEJMcibr1214975 · doi:10.1056/nejmcibr1214975
- Bachur, 1982, Nuclear catalyzed antibiotic free radical formation, Cancer Res., 42, 1078
- 2007, Molecular basis of anthracycline-induced cardiotoxicity, Heart Metab., 35, 1
- Lowe, 1980, Adriamycin and daunomycin dose-dependent effects upon contractions of isolated rat myocytes, Cancer Chemother. Pharmacol., 5, 61, 10.1007/BF00578564 · doi:10.1007/bf00578564
- Bow, 1998, Infection risk and cancer chemotherapy: The impact of the chemotherapeutic regimen in patients with lymphoma and solid tissue malignancies, J. Antimicrob. Chemother., 41, 1, 10.1093/jac/41.suppl_4.1 · doi:10.1093/jac/41.suppl_4.1
- Bhatnagar, 2005, Pancytopenia in children: Etiological profile, J. Trop. Pediatr., 51, 236, 10.1093/tropej/fmi010 · doi:10.1093/tropej/fmi010
- Landier, 2016, Ototoxicity and cancer therapy, Cancer, 122, 1647, 10.1002/cncr.29779 · doi:10.1002/cncr.29779
- Cappaert, 2005, Acceleration of cisplatin ototoxicity by perilymphatic application of 4-methylthiobenzoic acid, Hear. Res., 203, 80, 10.1016/j.heares.2004.10.012 · doi:10.1016/j.heares.2004.10.012
- Levi, 2015, Anti-Müllerian Hormone Is a Marker for Chemotherapy-Induced Testicular Toxicity, Endocrinology, 156, 3818, 10.1210/en.2015-1310 · doi:10.1210/en.2015-1310
- Meijer, 2021, Recommendations for Age-Appropriate Testing, Timing, and Frequency of Audiologic Monitoring During Childhood Cancer Treatment: An International Society of Paediatric Oncology Supportive Care Consensus Report, JAMA Oncol., 7, 1550, 10.1001/jamaoncol.2021.2697 · DOI
Cited by
Biosynthesis of Gold and Silver Nanoparticles Using Phytochemical Compounds
Zuhrotun, A., Oktaviani, D. J., & Hasanah, A. N. (2023) · Molecules · doi:10.3390/molecules28073240 · Cited by 281
Overcoming Barriers in Cancer Biology Research: Current Limitations and Solutions
(2025) · doi:10.3390/cancers17132102 · Cited by 44
MDM2 inhibition in the treatment of glioblastoma: From concept to clinical investigation
Pellot Ortiz, K. I., Rechberger, J. S., Nonnenbroich, L. F., Daniels, D. J., & Sarkaria, J. N. (2023) · Biomedicines · doi:10.3390/biomedicines11071879 · Cited by 30
Li, X., Huang, Z., Liao, Z., Liu, A., & Huo, S. (2023) · Nanoscale · doi:10.1039/d2nr06621a · Cited by 13
Metadata
- Authors
- van den Boogaard, W. M. C., Komninos, D. S. J., & Vermeij, W. P.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2022-01-26
- Volume
- 14
- Issue
- 3
- Pages
- 627
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W4210395111
- Cited by
- 458
- References
- 149
- FWCI
- 31.22
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- Oncode Institute (-)
- ADPS Longevity Research Award (-)
- Regiodeal Foodvalley (162135)
- BBoL (NWO-ENW) (737.016.015)
- ZonMW Memorabel (733050810)
- EJP-RD (RD20-113)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.